Greater Chicago Area, United States, March 2025 – Astellas Pharma has appointed Connie Gonzalez as Director, Global Talent Development. In this role, she will be responsible for shaping global learning strategies, leadership development, and talent advancement initiatives to drive a high-performing workforce. With a strong background in early career programs, inclusion, and workforce development, Connie brings a wealth of experience in building talent strategies that align with business growth and innovation.
Prior to joining Astellas Pharma, Connie was Senior Manager, GCO Diversity, Inclusion, and Belonging at Amgen, where she played a pivotal role in advancing DEI initiatives and fostering inclusive workplace practices. Earlier, she served as Senior Manager, Early Career Development Programs at Horizon Therapeutics, focusing on talent pipeline strategies, university relations, and career readiness programs.
Before that, Connie led Early Talent Programs at American Family Insurance, where she developed internship pipelines and leadership development programs. She also spent over a decade at Baxter International, holding various roles including Senior Manager, Rotational Development Programs & Global Inclusion & Diversity, where she spearheaded global talent initiatives, workforce planning, and leadership training programs.
Connie began her career at Abbott, where she managed intern programs, university recruitment, and early-career development efforts. Her expertise in talent acquisition, strategic workforce planning, and organizational development has positioned her as a key leader in shaping workforce strategies for global organizations.
Connie holds a strong background in strategic workforce planning and leadership development and has played a crucial role in advancing diversity and talent engagement across industries.
About Astellas Pharma
Astellas Pharma is a leading global pharmaceutical company committed to advancing scientific innovation to address unmet medical needs. With a presence in approximately 70 countries and a workforce of over 14,000 employees, Astellas focuses on research, development, and commercialization of groundbreaking therapies that improve patient lives.
By integrating cutting-edge science and value-driven innovation, Astellas continues to drive medical advancements in oncology, regenerative medicine, immunology, and neurology, ensuring a patient-centric approach to healthcare.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
